MANE
NYSE ·

Veradermics Inc

Mid-Cap Stocks
$100.10
+32.26 (+47.55%)
As of Apr 27, 10:10 PM ET ·
MANE News1 articles
Veradermics Soars After Hair-Loss Drug Meets Trial Goals
Veradermics shares jumped 40% after its oral hair-loss drug VDPHL01 met all main goals in a Phase 2/3 trial, with patients seeing significant hair count increases.
Markets